Evaluation of the rationality and feasibility of the grouping method for centralized procurement of insulin drugs in Wuhan based on the results of questionnaire survey among endocrinology physicians
- VernacularTitle:基于内分泌科医师问卷调查结果评价武汉市胰岛素类药品集中采购分组办法的合理性及可行性
- Author:
Huizi HU
1
,
2
,
3
;
Xiaotong WEN
2
,
3
;
Ying YANG
2
,
3
;
Lining MAO
2
,
3
;
Zhaolun WANG
2
,
3
;
Jia LUO
2
,
3
;
Weichun ZHANG
1
,
2
,
3
;
Zongfu MAO
2
,
3
;
Dan CUI
2
Author Information
1. School of Management，Hubei University of Chinese Medicine，Wuhan 430065，China
2. Global Health Institute，Wuhan University，Wuhan 430071，China
3. School of Health Sciences，Wuhan University，Wuhan 430071，China
- Publication Type:Journal Article
- Keywords:
insulin;
clinical conversion and substitution
- From:
China Pharmacy
2022;33(6):666-672
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate t he attitude of endocrinology physicians to clinical conversion and substitution of insulin drugs ，and to provide basis for improving the centralized procurement program of insulin. METHODS The proportion of convertible and substitutable insulin recognized by endocrinology physicians was investigated by questionnaire from 4 dimensions： intergenerational level ，bargaining group level ，common name level and brand/specification level. The subjects were endocrinology physicians in the third grade class A general hospitals in Nanchang. RESULTS A total of 89 questionnaires were successfully distributed，accounting for 80.2％ of the on-the-job endocrinology physicians （111 in total ）in the third grade class A general hospitals in Nanchang. Eighty-nine questionnaires were collected ，one of which was invalid ，and the effective rate was 98.9％. At the intergenerational level ，93.2％ of endocrinology physicians preferred insulin analogues. At the bargaining group level ，the weighted average of the convertible ratio between group 3 and group 4 approved by physicians was 63.9％. At the levels of common name and brand/specification ，the weighted averages of convertible proportion of each group were more than 70％. CONCLUSIONS The method of insulin grouping in Wuhan is reasonable which can complete clinical conversion and substitution of insulin in the group safely. It is suggested to cancel long-acting human insulin group. The weighted average of the proportion of convertible and substitutable drugs in the group is high. It is suggested to increase the agreed purchase volume of insulin and conduct“volume price linked ”negotiations. When the surveyed physicians choose the initial treatment scheme of insulin ，they pay more attention to the factors such as efficacy and safety ，so the replacement of insulin should be based on the clinical efficacy and drug safety.
